161 related articles for article (PubMed ID: 34427336)
1. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
[TBL] [Abstract][Full Text] [Related]
2. Matrix-dependent absorption of 8-methoxypsoralen in extracorporeal photopheresis.
Hähnel V; Weber I; Tuemmler S; Graf B; Gruber M; Burkhardt R; Ahrens N
Photochem Photobiol Sci; 2020 Aug; 19(8):1099-1103. PubMed ID: 32638713
[TBL] [Abstract][Full Text] [Related]
3. A simplified extracorporeal photopheresis procedure based on single high-dose ultraviolet A light irradiation shows similar in vitro efficacy.
Buchele V; Hackstein H
Transfusion; 2021 Mar; 61(3):883-893. PubMed ID: 33300629
[TBL] [Abstract][Full Text] [Related]
4. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
[TBL] [Abstract][Full Text] [Related]
5. A method for the quantification of 8-methoxypsoralen by mass spectrometry for offline extracorporeal photopheresis.
Hähnel V; Dormann F; Nitsopoulos A; Friedle A; Ahrens N
Photochem Photobiol Sci; 2017 Feb; 16(2):193-200. PubMed ID: 27976780
[TBL] [Abstract][Full Text] [Related]
6. Assessment of 8-methoxypsoralen and ultraviolet a light effects on human stroma generation and function.
Legitimo A; Consolini R; Bencivelli W; Crimaldi G; Migliaccio P; Mosca F
Acta Haematol; 2006; 116(3):192-7. PubMed ID: 17016038
[TBL] [Abstract][Full Text] [Related]
7. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
Shephard SE; Nestle FO; Panizzon R
Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
[TBL] [Abstract][Full Text] [Related]
9. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
10. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
[TBL] [Abstract][Full Text] [Related]
11. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
[TBL] [Abstract][Full Text] [Related]
12. A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
Laulhé M; Lefebvre S; Le Broc-Ryckewaert D; Pierre M; Ferry A; Delorme B
PLoS One; 2019; 14(3):e0212835. PubMed ID: 30822323
[TBL] [Abstract][Full Text] [Related]
13. Psoralen and UVA light: an in vitro investigation of multiple immunological mechanisms underlying the immunosuppression induction in allograft rejection.
Legitimo A; Consolini R; Di Stefano R; Bencivelli W; Mosca F
Blood Cells Mol Dis; 2002; 29(1):24-34. PubMed ID: 12482400
[TBL] [Abstract][Full Text] [Related]
14. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
[TBL] [Abstract][Full Text] [Related]
15. The North American experience with photopheresis.
Zic JA; Miller JL; Stricklin GP; King LE
Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
[TBL] [Abstract][Full Text] [Related]
17. Updating ECP action mechanisms.
Heshmati F
Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis and the cellular mechanisms: Effects of 8-methoxypsoralen and UVA treatment on red blood cells, platelets and reactive oxygen species.
Budde H; Mohr L; Bogeski I; Riggert J; Legler TJ
Vox Sang; 2023 Sep; 118(9):775-782. PubMed ID: 37401421
[TBL] [Abstract][Full Text] [Related]
19. The lack of efficacy of 4,6,6'-trimethylangelicin to induce immune suppression in an animal model for photopheresis: a comparison with 8-MOP.
van Iperen HP; Brun BM; Caffieri S; Dall'Acqua F; Gasparro FP; Beijersbergen Henegouwen GM
Photochem Photobiol; 1996 May; 63(5):577-82. PubMed ID: 8628748
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of chronic graft-versus-host disease in patients treated with extracorporeal photochemotherapy.
Motolese E; Rubegni P; Poggiali S; Motolese PA; Marotta G; Russo L; D'Ascenzo G; Carcagni MR; Fruschelli M; Motolese I; Fimiani M
Eur J Ophthalmol; 2007; 17(6):961-9. PubMed ID: 18050124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
